1 / 2

Vaccines Market by Type and Geography - Forecast and Industry Analysis 2020-2024

The global vaccines market size has the potential to grow by USD 13.81 billion during 2020-2024. The marketu2019s growth momentum will accelerate throughout the forecast period.

sarahbennu
Download Presentation

Vaccines Market by Type and Geography - Forecast and Industry Analysis 2020-2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The global vaccines market size has the potential to grow by USD 13.81 billion during 2020-2024. The market’s growth momentum will accelerate throughout the forecast period. Technavio has been monitoring the global vaccines market and the market is poised to grow by USD 13.81 billion during 2020-2024, progressing at a CAGR of almost 7% during the forecast period. Request Free Sample Pages The market is driven by the increasing use of adjuvants in vaccines. In addition, the development of nanoparticle vaccines is anticipated to further boost the growth of the vaccines market. The growing need to improve the success rate of current vaccines is leading researchers to developing vaccines to fight emerging new pathogens and re-emerging pathogens. As a result, they are using suitable adjuvants that are crucial for enhancing vaccine potency. Adjuvants such as immunologic adjuvants improve the humoral and cell- mediated immune response to vaccine antigens. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Major Five Vaccines Market Companies: Bavarian Nordic AS Bavarian Nordic AS is headquartered in Denmark and operates the business under the business segment: Pharmaceuticals. The company offers IMVAMUNE/IMVANEX, which is an MVA-BN non-replicating smallpox vaccine. CSL Ltd. CSL Ltd. is headquartered in Australia and offers products through the following two business units: CSL Behring and Seqirus. The company offers vaccines such as

  2. AFLURIA, FLUCELVAX, FLUAD, and FLUCELVAX TETRA to end-users such as hospitals and pharmacies. Emergent BioSolutions Inc. Emergent BioSolutions Inc. is headquartered in the US and has business operations under the business segment: Pharmaceuticals. The company offers vaccines such as ACAM2000, BioThrax, VAXCHORA, and Vivotif to end-users such as hospitals and pharmacies. GlaxoSmithKline Plc GlaxoSmithKline Plc is headquartered in the UK and offers products through the following business segments: Pharmaceuticals, Vaccines, and Consumer healthcare. The company offers vaccines such as Ambirix, BEXSERO, BOOSTRIX, and CERVARIX to end-users such as hospitals and pharmacies. Inovio Pharmaceuticals Inc. Inovio Pharmaceuticals Inc. is headquartered in the US and offers products through the business segment: Biopharmaceuticals. The company offers vaccines such as VGX- 3100 and PENNVAX-GP to end-users such as hospitals and pharmacies. Vaccines Type Outlook (Revenue, USD Million, 2020-2024) Prophylactic vaccines Therapeutic vaccines • • Vaccines Regional Outlook (Revenue, USD Million, 2020-2024) Asia Europe North America ROW • • • • Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report

More Related